BioXcel Therapeutics, Inc. Common Stock (BTAI)
BioXcel Therapeutics, Inc. Common Stock (BTAI) has reported earnings 20 times since Aug 10, 2021. The stock moves an average of ±11.12% the day after reporting, closing higher 35.0% of the time. Its largest post-earnings gain was +29.41% (Nov 10, 2022) and its largest decline was -41.4% (Aug 14, 2023). The next earnings report is predicted for 2026-11-13 (estimated).
Earnings reactions
How BTAI moved on each past earnings report.
Earnings Impact
Total Earnings
20
Avg Abs. Movement
±11.12%
Positive %
35.0%
Negative %
65.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 15, 2026 | ☀ PRE | -5.35% | open_in_new |
| Mar 27, 2026 | ☀ PRE | -7.35% | open_in_new |
| Nov 12, 2025 | ☀ PRE | -16.01% | open_in_new |
| Aug 12, 2025 | ☀ PRE | +5.48% | open_in_new |
Earnings Count
20
Total earnings in dataset
Avg Abs. Movement
±11.12%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260901 | open_in_new SEC.gov |
| 8-K | 20260828 | open_in_new SEC.gov |
| 8-K | 20260825 | open_in_new SEC.gov |
| 8-K | 20260824 | open_in_new SEC.gov |
| 3 | 20260814 | open_in_new SEC.gov |
| 4 | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| 10-Q | 20260813 | open_in_new SEC.gov |
| 8-K | 20260811 | open_in_new SEC.gov |
| 8-K | 20260803 | open_in_new SEC.gov |
Frequently asked about BTAI earnings
When does BioXcel Therapeutics, Inc. Common Stock report earnings next? expand_more
BioXcel Therapeutics, Inc. Common Stock (BTAI)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does BTAI stock move after earnings? expand_more
Over 20 reports, BTAI has moved an average of ±11.12% the session after earnings, closing higher 35.0% of the time.
What was BTAI's biggest post-earnings move? expand_more
BTAI's largest post-earnings gain on record was +29.41% on Nov 10, 2022, and its largest decline was -41.4% on Aug 14, 2023.
Where can I find BioXcel Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of BioXcel Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right